Mehmet ASIL, Muharrem KESKİN, Murat BIYIK, Pembe OLTULU, Hüseyin ATASEVEN, Ramazan DERTLİ, Ali DEMİR, Salim NEŞELOĞLU, Özcan EREL, Hakkı POLAT

Dynamic thiol-disulfide homeostasis is disturbed in hepatitis B virus-related chronic hepatitis and liver cirrhosis

Background/aim: Thiol-disulfide homeostasis is an important antioxidant defense mechanism. This study was conducted to investigatedynamic thiol-disulfide homeostasis in patients with hepatitis B virus-related chronic hepatitis and liver cirrhosis.Materials and methods: Seventy-one treatment-naive patients with chronic hepatitis B (CHB), 50 patients with hepatitis B virusassociated liver cirrhosis, and 45 healthy controls were included in the study. Serum total and native thiol concentrations and serumdisulfide concentrations were measured using an automated method.Results: Mean serum total thiol concentrations in the control, CHB, and cirrhosis groups were 481.64 ± 37.87 µmol/L, 438.50 ± 71.35µmol/L, and 358.07 ± 80.47 µmol/L, respectively (P < 0.001), and mean serum native thiol concentrations in the control, CHB, andcirrhosis groups were 452.92 ± 36.43 µmol/L, 400.16 ± 65.92 µmol/L, and 328.15 ± 74.91 µmol/L, respectively (P < 0.001). Mean serumdisulfide concentrations in the control, CHB, and cirrhosis groups were 14.38 ± 3.38 µmol/L, 19.19 ± 6.16 µmol/L, and 14.98 ± 5.53µmol/L, respectively (P < 0.001). There was a progressive decrease in both mean serum native and total thiol concentrations parallel tothe liver fibrosis stage.Conclusion: : Thiol-disulfide homeostasis is disturbed in patients with hepatitis B virus-related chronic hepatitis and liver cirrhosis.

PDF

___

Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015; 386: 1546-1555.
Balmasova IP, Yushchuk ND, Mynbaev OA, Alla NR, Malova ES, Shi Z, Gao CL. Immunopathogenesis of chronic hepatitis B. World J Gastroenterol 2014; 20: 14156-14171.
Li X, Liu X, Tian L, Chen Y. Cytokine-mediated immunopathogenesis of hepatitis B virus infections. Clin Rev Allerg Immu 2016; 50: 41-54.
Zhang W, Yue B, Wang GQ, Lu SL. Serum and ascites levels of macrophage migration inhibitory factor, TNF-and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis. Hepatobiliary Pancreat Dis Int 2002; 1: 577-580.
Asil M, Dertli R. Serum soluble TWEAK levels are decreased in treatment naive noncirrhotic chronic hepatitis B patients. Medicine (Baltimore) 2016; 95: e4763.
Demirdag K, Yilmaz S, Ozdarendeli A, Ozden M, Kalkan A, Kilic S. Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B. Hepatogastroenterology 2002; 50: 766-770.
Tanyalcin T, Taskiran D, Topalak O, Batur Y, Kutay F. The effects of chronic hepatitis C and B virus infections on liver reduced and oxidized glutathione concentrations. Hepatol Res 2000; 18: 104-109.
Bolukbas C, Bolukbas FF, Horoz M, Aslan M, Celik H, Erel O. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis 2005; 5: 95.
Ivanov AV, Valuev-Elliston VT, Tyurina DA, Ivanova ON, Kochetkov SN, Bartosch B, Isaguliants MG. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget 2017; 8: 3895-3932.
Piciocchi M, Cardin R, Cillo U, Vitale A, Cappon A, Mescoli C, Guido M, Rugge M, Burra P, Floreani A et al. Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis. Transl Res 2016; 168: 122-133.
Winterbourn CC, Hampton MB. Thiol chemistry and specificity in redox signaling. Free Radic Biol Med 2008; 45: 549-561.
Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010; 48: 749-762.
Erel O, Neselioglu S. A novel and automated assay for thiol/ disulphide homeostasis. Clin Biochem 2014; 47: 326-332.
Ates I, Ozkayar N, Inan B, Yilmaz FM, Topcuoglu C, Neselioglu S, Erel O, Dede F, Yılmaz N. Dynamic thiol/disulphide homeostasis in patients with newly diagnosed primary hypertension. J Am Soc Hypertens 2016; 10: 159-166.
Yuksel M, Ates I, Kaplan M, Alışık M, Erel Ö, Saygılı F, Kayaçetin E. The dynamic thiol/disulphide homeostasis in inflammatory bowel disease and its relation with disease activity and pathogenesis. Int J Colorectal Dis 2016; 31: 1229-1231.
Ates I, Kaplan M, Yuksel M, Mese D, Alisik M, Erel Ö, Yılmaz N, Guler S. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine 2016; 51: 47-51.
Asil M, Dertli R, Biyik M, Yolacan R, Erel O, Neselioglu S, Ataseven H, Polat H, Demir A. Dynamic thiol-disulfide homeostasis is disturbed in patients with non-alcoholic fatty liver disease. J Lab Med 2018; 42: 31-38.
Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
Köroğlu E, Canbakan B, Atay K, Hatemi İ, Tuncer M, Dobrucalı A, Sonsuz A, Gültepe İ, Şentürk H. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease. Turk J Gastroenterol 2016; 27: 361-366.
Yesilova Z, Yaman H, Oktenli C, Ozcan A, Uygun A, Cakir E, Sanioglu Y, Erdil A, Ateş Y, Aslan M et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2005; 100: 850-855.
Severi T, Ying C, Vermeesch JR, Cassiman D, Cnops L, Verslype C, Fevery J, Arckens L, Neyts J, van Pelt JF. Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells. Mol Cell Biochem 2006; 290: 79-85.
Valgimigli M, Valgimigli L, Trerè D, Gaiani S, Pedulli GF, Gramantieri L, Bolondi L. Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation. Free Radic Res 2002; 36: 939-948.
Şen V, Uluca Ü, Ece A, Kaplan İ, Bozkurt F, Aktar F, Bağlı S, Tekin R. Serum prolidase activity and oxidant–antioxidant status in children with chronic hepatitis B virus infection. Ital J Pediatr 2014; 40: 95.
Sun FK, Gao S, Fan YC, Shi CH, Zhang ZH, Wang LY, Li F, Li XY, Ji XY, Zhao J et al. High promoter methylation levels of glutathione-S-transferase M3 predict poor prognosis of acuteon-chronic hepatitis B liver failure. Hepatol Res 2017; 47: 566- 573.
Tasdelen FN, Aydin BK, Sarikaya H, Tanyel E, Esen S, Sunbul M, Leblebicioğlu H. Oxidative stress and antioxidant defense in patients with chronic hepatitis B. Clin Lab 2012; 58: 273- 280.
Duygu F, Karsen H, Aksoy N, Taskin A. Relationship of oxidative stress in hepatitis B infection activity with HBV DNA and fibrosis. Ann Lab Med 2012; 32: 113-118.
Poungpairoj P, Whongsiri P, Suwannasin S, Khlaiphuengsin A, Tangkijvanich P, Boonla C. Increased oxidative stress and RUNX3 hypermethylation in patients with hepatitis B virusassociated hepatocellular carcinoma (HCC) and induction of RUNX3 hypermethylation by reactive oxygen species in HCC cells. Asian Pac J Cancer Prev 2015; 16: 5343-5348.
Jung SY, Kim YJ. C-terminal region of HBx is crucial for mitochondrial DNA damage. Cancer Lett 2013; 331: 76-83.